SIRT1 and diabetes mellitus: MiR-217/SIRT1 interaction has been revealed in a number of studies to contribute to the progression of age-related pathological/morbid conditions involving oxidative stress such as CVD, atherosclerosis, diabetes, neurodegenerative diseases and cancer [27].